Biotechnology Research · Bayern
Eximmium is a biotechnology company in Munich, Germany, and Singapore and a member of the BioIP Holdings group. The company was founded in April 2021 and aims at the development of novel, highly specific antibodies to improve treatment options and companion diagnostics for cancer patients.